Save
Anticoagulation Stewardship from a Global Perspective
ISTH Academy, Faculty / Presenters, 4171757
Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults
ISTH Academy, Ang Li, 4174851
Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia
ISTH Academy, , 4174852
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study: linkage disequilibrium with prothrombin mutation
ISTH Academy, Bengt Zöller, 4174903
Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation
ISTH Academy, Faculty / Presenters, 4174902
Impact of peptidylarginine deiminase 4 (PAD4) deficiency in a fecal-induced peritonitis model of sepsis
ISTH Academy, Patricia Liaw, 4174901
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause
ISTH Academy, Johanna Gebhart, 4174900
Detection of SARS-CoV-2 in bone marrow megakaryocytes and elevated emperipolesis in COVID-19 patients with thrombocytopenia
ISTH Academy, Faculty / Presenters, 4174899
Platelet autoantibodies have an impact on the platelet count in patients
ISTH Academy, Faculty / Presenters, 4174898
Association between preoperative platelet count and perioperative cardiovascular events after noncardiac surgery
ISTH Academy, Faculty / Presenters, 4174897
Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count
ISTH Academy, Faculty / Presenters, 4174896
Proteomic analysis indicates lower abundance of platelet α-granule proteins in Glanzmann thrombasthenia
ISTH Academy, Rolf Urbanus, 4174895
Sialylated glycoproteins bind to Siglec-9 in a cis manner on platelets to suppress platelet activation
ISTH Academy, Dongfeng Zeng, 4174894
Lupus anticoagulant and antiprothrombin antibodies: embracing the future
ISTH Academy, Faculty / Presenters, 4174893
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study
ISTH Academy, Faculty / Presenters, 4174892
Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia
ISTH Academy, , 4174891
Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults
ISTH Academy, Ang Li, 4174890
Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trial
ISTH Academy, Faculty / Presenters, 4174889
Association of fibrinogen α, fibrinogen γ', and sialylated fibrinogen with development of ischemic stroke in patients with recently diagnosed type 2 diabetes
ISTH Academy, Faculty / Presenters, 4174888
Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics
ISTH Academy, , 4174887
Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study
ISTH Academy, Faculty / Presenters, 4174886
Real-world evaluation of a novel automated method for measuring ADAMTS-13 activity using the Ceveron s100 analyzer
ISTH Academy, Faculty / Presenters, 4174885
Insights from in vitro global assays on possible doses of concomitant hemostatic agents in the presence of NXT007 in hemophilia A
ISTH Academy, Faculty / Presenters, 4174884
Angiostatin—a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology
ISTH Academy, Paul Jurasz, 4174883
Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S
ISTH Academy, Anne Angelillo-Scherrer, 4174882
Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study
ISTH Academy, Faculty / Presenters, 4174881
P-Selectin(g) a diagnostic biomarker in heparin-induced thrombocytopenia
ISTH Academy, James Michael, 4174880
The diagnostic value of the platelet function analyzer in mild to moderate bleeding disorders
ISTH Academy, Floor Heubel-Moenen, 4174879
Empiricism, cancer, venous thromboembolism, and anticoagulation failures
ISTH Academy, Robert McBane, 4174878
How to manage safely direct oral anticoagulants in patients undergoing a neuraxial procedures? No definite answer yet!
ISTH Academy, Marc Samama, 4174877
Endothelial colony-forming cells to study bleeding or vascular malformation disorders - opportunities and limitations
ISTH Academy, Veerle Labarque, 4174831
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance
ISTH Academy, Faculty / Presenters, 4174832
Untargeted peptidomics of human blood clot degradomes induced by snake venoms
ISTH Academy, Manjunatha Kini, 4174833
Putting the brakes on thromboinflammation: Siglec-9 and platelet sialylation as a novel regulatory axis
ISTH Academy, Fabrice COGNASSE, 4174834
Platelet autoantibodies have been, and continue to be, clinically relevant in immune thrombocytopenia
ISTH Academy, Hanny Al-Samkari, 4174835
Hemophilia gene therapy enters clinical practice aided by clinical guidance on management of transaminase rise
ISTH Academy, Michiel Coppens, 4174836
Attempts to align research in thrombosis and hemostasis with the In Vitro Diagnostic Medical Device Regulation (IVDR, European Union) requirements
ISTH Academy, Faculty / Presenters, 4174837
How to manage safely direct oral anticoagulants in patients undergoing a neuraxial procedures? No definite answer yet!
ISTH Academy, Marc Samama, 4174838
Empiricism, cancer, venous thromboembolism, and anticoagulation failures
ISTH Academy, Robert McBane, 4174839
The diagnostic value of the platelet function analyzer in mild to moderate bleeding disorders
ISTH Academy, Floor Heubel-Moenen, 4174840
P-Selectin(g) a diagnostic biomarker in heparin-induced thrombocytopenia
ISTH Academy, James Michael, 4174841
Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study
ISTH Academy, Faculty / Presenters, 4174842
Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S
ISTH Academy, Anne Angelillo-Scherrer, 4174843
Angiostatin—a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology
ISTH Academy, Paul Jurasz, 4174844
Insights from in vitro global assays on possible doses of concomitant hemostatic agents in the presence of NXT007 in hemophilia A
ISTH Academy, Faculty / Presenters, 4174845
Real-world evaluation of a novel automated method for measuring ADAMTS-13 activity using the Ceveron s100 analyzer
ISTH Academy, Faculty / Presenters, 4174846
Risk factors for venous thrombosis after discharge from medical hospitalizations: the Medical Inpatient Thrombosis and Hemostasis study
ISTH Academy, Faculty / Presenters, 4174847
Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics
ISTH Academy, , 4174848
Association of fibrinogen α, fibrinogen γ', and sialylated fibrinogen with development of ischemic stroke in patients with recently diagnosed type 2 diabetes
ISTH Academy, Faculty / Presenters, 4174849
Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trial
ISTH Academy, Faculty / Presenters, 4174850
Attempts to align research in thrombosis and hemostasis with the In Vitro Diagnostic Medical Device Regulation (IVDR, European Union) requirements
ISTH Academy, Faculty / Presenters, 4174876
Annoucements
ISTH Academy, Faculty / Presenters, 4174904
Treatment and outcomes after on-treatment recurrent venous thromboembolism in patients with cancer: a post hoc analysis of the Hokusai venous thromboembolism cancer study
ISTH Academy, Faculty / Presenters, 4174853
Lupus anticoagulant and antiprothrombin antibodies: embracing the future
ISTH Academy, Faculty / Presenters, 4174854
Sialylated glycoproteins bind to Siglec-9 in a cis manner on platelets to suppress platelet activation
ISTH Academy, Dongfeng Zeng, 4174855
Proteomic analysis indicates lower abundance of platelet α-granule proteins in Glanzmann thrombasthenia
ISTH Academy, Rolf Urbanus, 4174856
Primary hemostasis in children with cirrhosis prior to liver transplantation: key roles of liver disease severity, von Willebrand factor, and platelet count
ISTH Academy, Faculty / Presenters, 4174857
Association between preoperative platelet count and perioperative cardiovascular events after noncardiac surgery
ISTH Academy, Faculty / Presenters, 4174858
Platelet autoantibodies have an impact on the platelet count in patients
ISTH Academy, Faculty / Presenters, 4174859
Detection of SARS-CoV-2 in bone marrow megakaryocytes and elevated emperipolesis in COVID-19 patients with thrombocytopenia
ISTH Academy, Faculty / Presenters, 4174860
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause
ISTH Academy, Johanna Gebhart, 4174861
Impact of peptidylarginine deiminase 4 (PAD4) deficiency in a fecal-induced peritonitis model of sepsis
ISTH Academy, Patricia Liaw, 4174862
Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation
ISTH Academy, Faculty / Presenters, 4174863
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study: linkage disequilibrium with prothrombin mutation
ISTH Academy, Bengt Zöller, 4174864
Annoucements
ISTH Academy, Faculty / Presenters, 4174865
Endothelial colony-forming cells to study bleeding or vascular malformation disorders - opportunities and limitations
ISTH Academy, Veerle Labarque, 4174870
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance
ISTH Academy, Faculty / Presenters, 4174871
Untargeted peptidomics of human blood clot degradomes induced by snake venoms
ISTH Academy, Manjunatha Kini, 4174872
Putting the brakes on thromboinflammation: Siglec-9 and platelet sialylation as a novel regulatory axis
ISTH Academy, Fabrice COGNASSE, 4174873
Platelet autoantibodies have been, and continue to be, clinically relevant in immune thrombocytopenia
ISTH Academy, Hanny Al-Samkari, 4174874
Hemophilia gene therapy enters clinical practice aided by clinical guidance on management of transaminase rise
ISTH Academy, Michiel Coppens, 4174875
Phase 2b trial of efficacy and safety of Factor XI Inhibition with MK-2060 for preventing AV graft thrombosis in hemodialysis patients
ISTH Academy, Faculty / Presenters, 4174148
Novo Nordisk on ISTH Academy
ISTH Academy, Faculty / Presenters, 4173823
Thrombotic response to mechanical circulatory support devices
ISTH Academy, Anna Waterhouse, 4171758
Refractory autoimmune heparin-induced thrombocytopenia following cardiac surgery
ISTH Academy, Tamam Bakchoul, 4171784
Importance of tubulin detyrosination in platelet biogenesis
ISTH Academy, , 4171783
Maternal platelet-derived factors induce trophoblastic LAIR2 expression to promote trophoblast invasion and inhibit platelet activation at the fetal-maternal interface
ISTH Academy, , 4171782
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis
ISTH Academy, , 4171781
Plasminogen and plasmin induce specialized proresolving mediators and promote efferocytosis via 5-lipoxygenase
ISTH Academy, Lirlândia Sousa, 4171780
Patients with cirrhosis have a disbalance between coagulation and fibrinolysis resulting in a prothrombotic phenotype
ISTH Academy, Faculty / Presenters, 4171779
Trends in home treatment and early discharge of patients with low-risk pulmonary embolism
ISTH Academy, Faculty / Presenters, 4171778
Causal insights into the role of metabolites in venous thromboembolism pathogenesis: a metabolome-wide Mendelian randomization study
ISTH Academy, , 4171777
Effect of direct oral anticoagulants in cirrhosis: an in vitro study
ISTH Academy, Lorenzo ALBERIO, 4171776
Patient and healthcare providers’ perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: a qualitative study
ISTH Academy, Leslie Skeith, 4171775
Clinical and radiologic characteristics of chronic thromboembolic pulmonary hypertension patients without a history of acute venous thromboembolism
ISTH Academy, Faculty / Presenters, 4171774
Activated factor XI–antithrombin and thrombin–antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non–small-cell lung cancer
ISTH Academy, Marina Marchetti, 4171773
2-Methoxybenzoic acid ameliorates arterial thrombosis via inhibiting carbon anhydrase activity in platelet
ISTH Academy, , 4171772
Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: a propensity score weighted analysis
ISTH Academy, Faculty / Presenters, 4171771
Plasmin cleavage of β2-glycoprotein I alters its structure and ability to bind to pathogenic antibodies
ISTH Academy, Thomas McDonnell, 4171770
Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases
ISTH Academy, ROBERT FLAUMENHAFT, 4171769
Multigene panel for thrombophilia testing in venous thromboembolism
ISTH Academy, Faculty / Presenters, 4171768
The incidence and risk of venous thromboembolism in patients with active malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM–iSVT review)
ISTH Academy, Faculty / Presenters, 4171767
Discrepancy between one-stage clotting and chromogenic factor VIII activity in women with hemophilia A and hemophilia A carriers: a retrospective clinical study
ISTH Academy, Yesim Dargaud, 4171766
Discrepancy between parallel anti-Xa and activated partial thromboplastin time is related to mortality in patients with Impella-supported cardiogenic shock
ISTH Academy, Christophe Vandenbriele, 4171765
An engineered Treg selective immunocytokine induces sustained immune modulation in a preclinical model of hemophilia A
ISTH Academy, , 4171764
Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study
ISTH Academy, Saskia Schols, 4171763
Direct oral anticoagulant failure in patients with venous thromboembolism—why and what next?
ISTH Academy, Faculty / Presenters, 4171762
Navigating the challenges of neuraxial anesthesia in patients with platelet and coagulation disorders: commentary on the ISTH SSC Delphi Consensus recommendations
ISTH Academy, Roy Khalife, 4171761
Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxes
ISTH Academy, John Puetz, 4171760
Criteria for home treatment of patients with acute pulmonary embolism (the Emergency Advisory and Research international board on Thrombosis and Hemostasis EARTH - rule): an international Delphi consensus study
ISTH Academy, Pierre-Marie Roy, 4171759

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings